New Issue of the IASLC Lung Cancer News - Now Available!

We are a global network of specialists working together to conquer lung and thoracic cancers worldwide.

IASLC Foundation

 

Donate to the IASLC Foundation

Remembering Dr. Adi Gazdar -
A Giant of the Field

 
The IASLC mourns the passing of this groundbreaking pathologist,
inspiring mentor and generous contributor to the IASLC Foundation.

We thank him for his significant contributions to the field. 

Participate in the IASLC Lung Cancer
Staging Project 

Featured Science and Communiqués

People with Severe Disabilities are at a Disadvantage for Early Detection and Treatment of Lung Cancer

Lung cancer patients with severe disabilities underwent less staging work-up and treatment and had slightly higher overall mortality compared to people with no disability.

Increased Survival in Patients with Metastatic NSCLC Receiving Treatment in Academic Centers

Patients with metastatic NSCLC receiving treatment at academic centers (ACs) have an increased 2-year survival compared to patients treated at community-based centers (CCs).

Active Surveillance of Lung Subsolid Nodules Reduces Unnecessary Surgery and Overtreatment

Subsolid nodules (SSN) can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.

Racial-Ethnic Disparities in the Quality of End-of-Life Care Among Lung Cancer Patients

Significant disparities in the quality of end-of-life lung cancer care were found among racial-ethnic minorities, with higher odds of experiencing potentially preventable medical encounters during end-of-life as compared with non-Hispanic whites.